🚀 VC round data is live in beta, check it out!
Kestra Medical Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Kestra Medical Technologies and similar public comparables like Shinva, Chengzhi, Sopharma, BioLife Solutions and more.
Kestra Medical Technologies Overview
About Kestra Medical Technologies
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Founded
2021
HQ
Employees
330
Website
Sectors
Financials (LTM)
EV
$1B
Kestra Medical Technologies Financials
Kestra Medical Technologies reported last 12-month revenue of $86M and negative EBITDA of ($89M).
In the same LTM period, Kestra Medical Technologies generated $42M in gross profit, ($89M) in EBITDA losses, and had net loss of ($122M).
Revenue (LTM)
Kestra Medical Technologies P&L
In the most recent fiscal year, Kestra Medical Technologies reported revenue of $60M and EBITDA of ($80M).
Kestra Medical Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $86M | XXX | $60M | XXX | XXX | XXX |
| Gross Profit | $42M | XXX | $24M | XXX | XXX | XXX |
| Gross Margin | 49% | XXX | 41% | XXX | XXX | XXX |
| EBITDA | ($89M) | XXX | ($80M) | XXX | XXX | XXX |
| EBITDA Margin | (103%) | XXX | (133%) | XXX | XXX | XXX |
| EBIT Margin | (143%) | XXX | (176%) | XXX | XXX | XXX |
| Net Profit | ($122M) | XXX | ($114M) | XXX | XXX | XXX |
| Net Margin | (142%) | XXX | (190%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Kestra Medical Technologies Stock Performance
Kestra Medical Technologies has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Kestra Medical Technologies' stock price is $23.32.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | 0.0% | XXX | XXX | XXX | $-1.95 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKestra Medical Technologies Valuation Multiples
Kestra Medical Technologies trades at 14.2x EV/Revenue multiple, and (13.9x) EV/EBITDA.
EV / Revenue (LTM)
Kestra Medical Technologies Financial Valuation Multiples
As of March 7, 2026, Kestra Medical Technologies has market cap of $1B and EV of $1B.
Equity research analysts estimate Kestra Medical Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Kestra Medical Technologies has a P/E ratio of (11.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 14.2x | XXX | 20.6x | XXX | XXX | XXX |
| EV/EBITDA | (13.9x) | XXX | (15.5x) | XXX | XXX | XXX |
| EV/EBIT | (9.9x) | XXX | (11.7x) | XXX | XXX | XXX |
| EV/Gross Profit | 29.1x | XXX | 50.8x | XXX | XXX | XXX |
| P/E | (11.1x) | XXX | (12.0x) | XXX | XXX | XXX |
| EV/FCF | (10.8x) | XXX | (13.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kestra Medical Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Kestra Medical Technologies Margins & Growth Rates
Kestra Medical Technologies' revenue in the last 12 month grew by 48%.
Kestra Medical Technologies' revenue per employee in the last FY averaged $0.3M.
Kestra Medical Technologies' rule of 40 is (55%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kestra Medical Technologies' rule of X is 16% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Kestra Medical Technologies Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 48% | XXX | 52% | XXX | XXX | XXX |
| EBITDA Margin | (103%) | XXX | (133%) | XXX | XXX | XXX |
| EBITDA Growth | (7%) | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (55%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 92% | XXX | — | XXX | XXX | XXX |
| G&A Expenses to Revenue | 79% | XXX | — | XXX | XXX | XXX |
| R&D Expenses to Revenue | 22% | XXX | 26% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 218% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Kestra Medical Technologies Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Shinva | XXX | XXX | XXX | XXX | XXX | XXX |
| Chengzhi | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| BioLife Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| Paul Hartmann | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kestra Medical Technologies M&A Activity
Kestra Medical Technologies acquired XXX companies to date.
Last acquisition by Kestra Medical Technologies was on XXXXXXXX, XXXXX. Kestra Medical Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Kestra Medical Technologies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialKestra Medical Technologies Investment Activity
Kestra Medical Technologies invested in XXX companies to date.
Kestra Medical Technologies made its latest investment on XXXXXXXX, XXXXX. Kestra Medical Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Kestra Medical Technologies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kestra Medical Technologies
| When was Kestra Medical Technologies founded? | Kestra Medical Technologies was founded in 2021. |
| Where is Kestra Medical Technologies headquartered? | Kestra Medical Technologies is headquartered in United States. |
| How many employees does Kestra Medical Technologies have? | As of today, Kestra Medical Technologies has over 330 employees. |
| Who is the CEO of Kestra Medical Technologies? | Kestra Medical Technologies' CEO is Brian Webster. |
| Is Kestra Medical Technologies publicly listed? | Yes, Kestra Medical Technologies is a public company listed on Nasdaq. |
| What is the stock symbol of Kestra Medical Technologies? | Kestra Medical Technologies trades under KMTS ticker. |
| When did Kestra Medical Technologies go public? | Kestra Medical Technologies went public in 2025. |
| Who are competitors of Kestra Medical Technologies? | Kestra Medical Technologies main competitors are Shinva, Chengzhi, Sopharma, BioLife Solutions. |
| What is the current market cap of Kestra Medical Technologies? | Kestra Medical Technologies' current market cap is $1B. |
| What is the current revenue of Kestra Medical Technologies? | Kestra Medical Technologies' last 12 months revenue is $86M. |
| What is the current revenue growth of Kestra Medical Technologies? | Kestra Medical Technologies revenue growth (NTM/LTM) is 48%. |
| What is the current EV/Revenue multiple of Kestra Medical Technologies? | Current revenue multiple of Kestra Medical Technologies is 14.2x. |
| Is Kestra Medical Technologies profitable? | No, Kestra Medical Technologies is not profitable. |
| What is the current EBITDA of Kestra Medical Technologies? | Kestra Medical Technologies has negative EBITDA and is not profitable. |
| What is Kestra Medical Technologies' EBITDA margin? | Kestra Medical Technologies' last 12 months EBITDA margin is (103%). |
| What is the current EV/EBITDA multiple of Kestra Medical Technologies? | Current EBITDA multiple of Kestra Medical Technologies is (13.9x). |
| What is the current FCF of Kestra Medical Technologies? | Kestra Medical Technologies' last 12 months FCF is ($114M). |
| What is Kestra Medical Technologies' FCF margin? | Kestra Medical Technologies' last 12 months FCF margin is (132%). |
| What is the current EV/FCF multiple of Kestra Medical Technologies? | Current FCF multiple of Kestra Medical Technologies is (10.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.